Cell-free DNA (cfDNA) analysis is transforming precision medicine, offering a non-invasive window into the body, particularly in the context of cancer. This journal collection, hosted by npj Precision ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major medical society recommends the test for screening.

Two measurable health markers, Vitamin D levels and physical activity, may independently slow biological aging at the ...

Clonal hematopoiesis (CH), the benign clonal expansion of hematopoietic stem cells, is often caused by somatic sequence variations in genes associated with hematologic malignancies. Over the past ...

Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

Researchers have resolved a 50-year-old scientific mystery by identifying the molecular mechanism that allows tissues to ...

A research team has discovered a crucial mechanism that underlies chemotherapy resistance and metastasis in small cell lung cancer (SCLC). Their study shows that the silencing of the RASA4 gene ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

By Priyanjana Pramanik, MSc. Researchers reveal why lung cancer in people who never smoked is increasing and explore how ...

When a cell divides, it performs a feat of microscopic choreography—duplicating its DNA and depositing it into two new cells.

A new software tool, ovrlpy, improves quality control in spatial transcriptomics, a key technology in biomedical research. Developed by the Berlin Institute of Health at Charité (BIH) in international ...